Literature DB >> 17098975

CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.

Yang Wang1, Mario Lobigs, Eva Lee, Aulikki Koskinen, Arno Müllbacher.   

Abstract

The flavivirus West Nile virus (WNV) can cause fatal encephalitis in humans and mice. It has recently been demonstrated, in an experimental model using WNV strain Sarafend and C57BL/6 mice, that both virus- and immune-mediated pathology is involved in WNV encephalitis, with CD8(+) T cells being the dominant subpopulation of lymphocyte infiltrates in the brain. Here, the role of activated WNV-immune CD8(+) T cells in mouse WNV encephalitis was investigated further. Passive transfer of WNV-immune CD8(+) T cells reduced mortality significantly and prolonged survival times of mice infected with WNV. Early infiltration of WNV-immune CD8(+) T cells into infected brains is shown, suggesting a beneficial contribution of these lymphocytes to recovery from encephalitis. This antiviral function was not markedly mediated by gamma interferon (IFN-gamma), as a deficiency in IFN-gamma did not affect mortality to two strains of WNV (Sarafend and Kunjin) or brain virus titres significantly. The cytolytic potential, as well as precursor frequency, of WNV-immune CD8(+) T cells were not altered by the absence of IFN-gamma. This was reflected in transfer experiments of WNV-immune CD8(+) T cells from IFN-gamma(-/-) mice into WNV-infected wild-type mice, which showed that IFN-gamma-deficient T cells were as effective as those from WNV-immune wild-type mice in ameliorating disease outcome. It is speculated here that one of the pleiotropic functions of IFN-gamma is mimicked by WNV-Sarafend-mediated upregulation of cell-surface expression of major histocompatibility complex antigens, which may explain the lack of phenotype of IFN-gamma(-/-) mice in response to WNV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098975     DOI: 10.1099/vir.0.81306-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Regulatory T cells shape the resident memory T cell response to virus infection in the tissues.

Authors:  Jessica B Graham; Andreia Da Costa; Jennifer M Lund
Journal:  J Immunol       Date:  2013-12-11       Impact factor: 5.422

2.  A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.

Authors:  Amelia K Pinto; Justin M Richner; Elizabeth A Poore; Pradnya P Patil; Ian J Amanna; Mark K Slifka; Michael S Diamond
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

3.  Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes.

Authors:  Curtis P McMurtrey; Alina Lelic; Paolo Piazza; Ayan K Chakrabarti; Eric J Yablonsky; Angela Wahl; Wilfried Bardet; Annette Eckerd; Robert L Cook; Rachael Hess; Rico Buchli; Mark Loeb; Charles R Rinaldo; Jonathan Bramson; William H Hildebrand
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

4.  The West Nile virus-like flavivirus Koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response.

Authors:  Natalie A Prow; Yin X Setoh; Rebecca M Biron; David P Sester; Kwang Sik Kim; Jody Hobson-Peters; Roy A Hall; Helle Bielefeldt-Ohmann
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

5.  Surface phenotype and functionality of WNV specific T cells differ with age and disease severity.

Authors:  Paolo Piazza; Curtis P McMurtrey; Alina Lelic; Robert L Cook; Rachel Hess; Eric Yablonsky; Luann Borowski; Mark B Loeb; Jonathan L Bramson; William H Hildebrand; Charles R Rinaldo
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

6.  A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus.

Authors:  Byron E E Martina; Petra van den Doel; Penelope Koraka; Geert van Amerongen; Gunther Spohn; Bart L Haagmans; Lisette B V Provacia; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

7.  Virus and host determinants of West Nile virus pathogenesis.

Authors:  Michael S Diamond
Journal:  PLoS Pathog       Date:  2009-06-26       Impact factor: 6.823

8.  IL-10 signaling blockade controls murine West Nile virus infection.

Authors:  Fengwei Bai; Terrence Town; Feng Qian; Penghua Wang; Masahito Kamanaka; Tarah M Connolly; David Gate; Ruth R Montgomery; Richard A Flavell; Erol Fikrig
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

9.  Zika virus infection during pregnancy protects against secondary infection in the absence of CD8+ cells.

Authors:  Blake Schouest; Brandon J Beddingfield; Margaret H Gilbert; Rudolf P Bohm; Faith Schiro; Pyone P Aye; Antonito T Panganiban; Diogo M Magnani; Nicholas J Maness
Journal:  Virology       Date:  2021-04-09       Impact factor: 3.616

10.  MHC class II-alpha chain knockout mice support increased viral replication that is independent of their lack of MHC class II cell surface expression and associated immune function deficiencies.

Authors:  Mohammed Alsharifi; Aulikki Koskinen; Danushka K Wijesundara; Jayaram Bettadapura; Arno Müllbacher
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.